Gardasil 9 syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FCKBU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,390
Award facts
- Contract value 100% obligated
- $28,389.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 Syringe 0.5mL, a human papillomavirus vaccine, with a ceiling value of $28,389.84. The contract, awarded on September 3, 2025, carries a firm fixed price structure and is classified as a non-set-aside competitive award. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio with the DLA encompasses a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, and medical devices across multiple therapeutic domains. This specific delivery order aligns with the company's established role as a key supplier within the DLA's pharmaceutical supply chain, supporting the broader federal healthcare infrastructure for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FCKBU?
SPE2DB25FCKBU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FCKBU worth?
The government has obligated $28,390 on SPE2DB25FCKBU.
Is contract SPE2DB25FCKBU an order under another contract?
Yes. SPE2DB25FCKBU is a delivery order under SPE2DB24D2013, an indefinite delivery contract.
Was contract SPE2DB25FCKBU competed?
The extent of competition for SPE2DB25FCKBU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award